Structural Characterization and Anti-Hyperuricemic Effect of a Mannogalactan from Armillariella Tabescens Mycelium.

Wenhua Guo,Junqiang Zhang,Hailan Deng,Yunbo Hao,Hao Chen,Yong Li,Wenna Zhang,Mei Zhang,Yan Chen
DOI: https://doi.org/10.1016/j.ijbiomac.2024.137152
IF: 8.2
2024-01-01
International Journal of Biological Macromolecules
Abstract:Hyperuricemia and its complications caused by purine metabolism disorder continue to occur, which require effective drug treatment with fewer side effects. This study explored the positive effects of a natural homogeneous polysaccharide (AT-W) from the mycelium of Armillariella tabescens in a mouse hyperuricemia model. Structural characterization showed that the average molecular weight of AT-W is 25.6 kDa, and it is composed of mannose, galactose, arabinose, and fucose, with molar percentages of 11.46:70.9:4.96:12.67. The main backbone of AT-W is composed of partially 3-O-methylated →6)-α-Galp-(1→, and the branches are mainly composed of α-Manp-(1→, →3)-α-Fucp-(1→. In vivo bioactivity evaluation showed AT-W could not only reduce serum uric acid levels by inhibiting the activity of xanthine oxidase, upregulating the expression of ABCG2 and OAT1, and downregulating the expression of URAT1 but also have a significant protective effect on renal damage caused by hyperuricemia. These findings indicate that AT-W has therapeutic potential for hyperuricemia diseases.
What problem does this paper attempt to address?